Eli Lilly Stock (LLY) Hits All-Time High Amid Post-Earnings Rally
Eli Lilly's stock surged to a record high of $966.55 on November 10, marking a 4.8% gain, as investor confidence grew following robust third-quarter earnings. The rally extended into the next session, with shares peaking at an intra-day high of $999.95.
Third-quarter EPS of $7.02 and revenue of $17.60 billion significantly outpaced Wall Street expectations, driven by strong sales of weight-loss drug Zepbound. This performance marks a stark reversal from earlier concerns over pharmaceutical price controls and demand fluctuations.